All Terrain Financial Advisors’s GSK GSK Stock Holding History

All Terrain Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,680	Closed	-$216K	–	200
2019 Q4	$216K	Hold	3,680	–	–	0.07%	140
2019 Q3	$196K	Sell	3,680 -80	-2%	-$4.12K	0.07%	156
2019 Q2	$188K	Buy	+3,760	New	+$189K	0.06%	156
2018 Q4	–	Sell	-4,240	Closed	-$213K	–	217
2018 Q3	$213K	Sell	4,240 -63	-1%	-$3.2K	0.09%	151
2018 Q2	$217K	Buy	4,303 +59	+1%	+$2.97K	0.1%	147
2018 Q1	$207K	Sell	4,244 -1,360	-24%	-$63.3K	0.09%	155
2017 Q4	$248K	Buy	+5,604	New	+$259K	0.11%	138

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

All Terrain Financial Advisors's GSK Position: Q1 2020 in Review

All Terrain Financial Advisors sold out of GSK (GSK) in Q1 2020, closing a stake of 3,680 shares — an estimated $216K sold.

All Terrain Financial Advisors first reported a position in GSK in Q4 2017 and held it in 7 quarters. The position peaked at $248K in Q4 2017. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

All Terrain Financial Advisors reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
All Terrain Financial Advisors sold 3,680 GSK shares in Q1 2020, an estimated $216K.
All Terrain Financial Advisors first reported a position in GSK in Q4 2017 and held it in 7 quarters.
All Terrain Financial Advisors's GSK position peaked at $248K in Q4 2017.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on All Terrain Financial Advisors's 13F filing for Q1 2020, filed 14 May 2020.